@GKangInd@harrys_67 Do we need to check the availability of Neutralizing Antibodies against the variants and choose for booster dose based on the level of NAbs?
As breakthrough infection are reported and some states indicated increase the Covid19 cases it is high time to screen for #neutralizingantibody against #OmicronVariant and understand community transmission or vaccine efficacy.
@snehamordani@MoHFW_INDIA@ICMRDELHI Sero-survey for Neutralizating Antibodies instead of Binding Antibodies against Variants will be more relevant now.
@GKangInd@OffCMCVellore@joy_mammen Will be interesting to know the Neutralizing Antibody levels among the 9.6% HCW who were re-infected after the second dose.
cPass sVNT a tool for highly accurate #SARSCoV2#immunitysurveillance of infected/recovered and/or vaccinated individuals, as well as drug and its use in longitudinal testing of recovered and/or vaccinated patients #vaccineIndia https://t.co/TqtppG9RWr @ICMRDELHI@DBTIndia
The #vaccines are here. How do we know they are #effective? Join this webinar to learn the importance of #serology testing in the next phase of #covid19 & how it may impact #publichealth policies.
29 January, 12:30 IST
Register: https://t.co/s5thYEhTz2
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2 https://t.co/fhRROkVKd7 found 95% of sero-positive individuals had NAbs and some prevailed for 6 months.
@IGIBSocial@GenScript#serosurveillance#COVID19Vaccination
Fantastic depiction of #gettested by @CharlieAdlard The image also reminds us the risk of Nasopharyngeal swabs in children and elderly. It's High time to switch for #salivatest for #covid19
Live-cell #barcoding can turn up to 35 samples into one! Barcoding for #masscytometry uses metal-labeled #antibodies that target cell-surface epitopes, allowing you to combine several samples together for better data consistency and workflow efficiencies.
https://t.co/aUKQSL7Kq8